The Patent Finder

Thar Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Thar Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Thar Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 8,399,023Crystallization method and bioavailability
Formerly held
Lapsed on the fee record
Ended Mar 19, 2025 · From the USPTO record
Lapsed on the fee recordEnded Mar 19, 2025From the USPTO record
US 8,389,512In vivo studies of crystalline forms of meloxicam
Formerly held
Lapsed on the fee record
Ended Mar 5, 2025 · From the USPTO record
Lapsed on the fee recordEnded Mar 5, 2025From the USPTO record
US 9,340,565Crystalline forms
Formerly held
Lapsed on the fee record
Ended May 17, 2024 · From the USPTO record
Lapsed on the fee recordEnded May 17, 2024From the USPTO record
US 9,334,296Crystallization method and bioavailability
Formerly held
Lapsed on the fee record
Ended May 10, 2024 · From the USPTO record
Lapsed on the fee recordEnded May 10, 2024From the USPTO record
US 8,124,603In vivo studies of crystalline forms of meloxicam
Formerly held
Lapsed on the fee record
Ended Feb 28, 2024 · From the USPTO record
Lapsed on the fee recordEnded Feb 28, 2024From the USPTO record
US 10,519,176Crystalline forms
Formerly held
Lapsed on the fee record
Ended Dec 31, 2023 · From the USPTO record
Lapsed on the fee recordEnded Dec 31, 2023From the USPTO record
US 9,169,279Crystallization method and bioavailability
Formerly held
Lapsed on the fee record
Ended Oct 27, 2023 · From the USPTO record
Lapsed on the fee recordEnded Oct 27, 2023From the USPTO record
US 10,323,052Crystallization method and bioavailability
Formerly held
Lapsed on the fee record
Ended Jun 18, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jun 18, 2023From the USPTO record
US 9,040,535Crystalline molecular comlpexes of tadalafil
Formerly held
Lapsed on the fee record
Ended May 26, 2023 · From the USPTO record
Lapsed on the fee recordEnded May 26, 2023From the USPTO record
US 8,980,868Oral forms of a phosphonic acid derivative
Formerly held
Lapsed on the fee record
Ended Mar 17, 2023 · From the USPTO record
Lapsed on the fee recordEnded Mar 17, 2023From the USPTO record
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited